AbbreviationsDMdiabetes mellitusGMDgestational diabetes mellitusNPHneutral protamine HagedornRCTrandomized controlled trialKey messageThe majority of trials used very tight criteria of either one or two values per week higher than the target values for pharmacologic diabetes therapy dose adjustment.IntroductionCarbohydrate disorders in pregnancy, including gestational diabetes mellitus (GMD) and pregestational diabetes mellitus (DM), are the most common morbidities complicating pregnancy, with short‐ and long‐term consequences to mothers, fetuses, and newborns. It has been estimated that up to 6–7% or more of all pregnancies are complicated by DM in pregnancy . The latest reports from the International Diabetes Federation estimate that, worldwide, approximately one in seven births in 2015 were complicated by some form of hyperglycemia during pregnancy .Management for women with carbohydrate disorders in pregnancy includes diet, physical activity, oral hypoglycemic agents or insulin as needed. The management of those women aims to achieve the best possible glycemic control, with normal or near normal glucose values while avoiding hypoglycemia. This management is effective in reducing maternal and neonatal morbidity and mortality .Nevertheless, the optimal schedule, frequency and timing of glucose monitoring remains disputable, as are the glycemic metabolic goals. Moreover, there is no evidence from randomized controlled trials (RCTs) to support any specific criteria for
Acta Obstetricia Et Gynecologica Scandinavica – Wiley
Published: Jan 1, 2018
Keywords: ; ; ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud